Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05506046
Other study ID # H22639
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date October 12, 2022
Est. completion date February 28, 2023

Study information

Verified date March 2023
Source Georgia State University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The investigators will conduct a message-exposure experiment with nationally representative samples of smokers, dual-users (cigarettes and e-cigarettes), and young adult non-smokers (aged 18-29). Experimental messages will address the reduction of nicotine in cigarettes. Participants will also complete a follow-up survey after 2 weeks, measuring their recall of the messages and behaviors since message exposure.


Description:

A national probability-based sample will be recruited to include 900 current exclusive smokers, 450 dual users, and 450 young adult (18-29) non-smokers, evenly split between men and women. The study will be conducted using a self-administered, online questionnaire via proprietary, web-assisted interviewing software. Participants are randomized to one of four conditions: - reduced nicotine messages - modified risk messages - a combination of reduced nicotine message and modified risk message - control messages with no cigarette-related content Participants will take part in two sessions: in session 1 (estimated at about 15 min) participants will see the messages and report immediate outcomes including risk perceptions. In session 2, which will take place 2 weeks after session 1, participants will complete a brief 5-minute survey measuring their recall of the messages and behaviors since message exposure.


Recruitment information / eligibility

Status Completed
Enrollment 1800
Est. completion date February 28, 2023
Est. primary completion date February 28, 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Being 18 years old or older: - Belonging to one of three groups of participants; 900 current exclusive smokers, 450 dual users (cigarettes and e-cigarettes), and 450 young adult (18-29) non-smokers, evenly split between men and women. - Enrolled in existing nationally representative panel where recruitment is based Exclusion Criteria: - None.

Study Design


Intervention

Behavioral:
Reduced nicotine message exposure
Participants will be shown two messages about harms of reduced nicotine cigarettes. The two messages will be drawn from a pool of five messages. The messages will communicate that reduced nicotine cigarettes will still have the rest of the harmful chemicals and cause diseases as the regular cigarettes, but they would make it easier to quit.
Modified risk message exposure
Participants will be shown two messages about electronic cigarettes as an alternative to regular cigarettes. The two messages will be drawn from a pool of five messages. The messages will communicate that electronic cigarettes are less likely than regular cigarettes to cause severe diseases such as lung cancer.
Combined message exposure (reduced nicotine + modified risk)
Participants will be shown two messages, one from the reduced nicotine message set and one modified risk message set.
Control message exposure
Participants will be shown two messages about drinking bottled water. These will be selected from a pool of five message. The messages display specific water products and describe hydration as a healthy activity.

Locations

Country Name City State
United States Georgia State University Atlanta Georgia

Sponsors (1)

Lead Sponsor Collaborator
Georgia State University

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Perceived health risk of VLNCs (absolute) Measured with a single item, assesses participant's perception of own risk of overall harm to health under conditions of smoking reduced nicotine cigarettes every day. Response options range from 1 (Not at all likely) to 5 (Extremely likely) and include "Don't know" Immediately after exposure
Secondary Interest in trying reduced nicotine cigarettes A single item measuring how interested a participant is in trying reduced nicotine cigarettes. Response options are from 1. not at all to 7. extremely and include "Don't know". Immediately after exposure
Secondary Perceived health risk of VLNCs (absolute) at post-test Measured with a single item, assesses participant's perception of own risk of overall harm to health under conditions of smoking reduced nicotine cigarettes every day. Response options range from 1 (Not at all likely) to 5 (Extremely likely) and include "Don't know" Two weeks after exposure
Secondary Intention to switch from cigarettes to electronic nicotine products A single item measuring intention (during the next 6 months) to switch completely from cigarettes to electronic nicotine products. Response options are from 1. not at all likely to 7. extremely likely and include "Don't know." Immediately after exposure
Secondary Perceived addictiveness of VLNCs A single item measuring participants' perception of likelihood developing addiction to reduced nicotine cigarettes under conditions of smoking them every day. Response options are from 1. Not at all likely to 5. Extremely likely and include "Don't know.' Immediately after exposure
Secondary VLNC Comparative Risk Perceptions A single item measuring perceptions of comparative risk of smoking reduced nicotine cigarettes vs regular cigarettes. Response options are from 1.Much less harmful to 5. Much more harmful and include "Don't know.' Immediately after exposure
Secondary VLNC Policy Support A single item measuring support for the policy to reduce nicotine by 95% in all cigarettes. Response options are from 1. Strongly Oppose to 5. Strongly Support and include "Don't know." Immediately after exposure
Secondary Perceived Message Effectiveness A three-item scale measuring to what extent participants think the messages they saw discourage them from wanting to smoke, make smoking seem unpleasant, and make them concerned about health risks of smoking.
Response options: Strongly Disagree (1) Neither Disagree nor Agree (4) Strongly Agree (7)
Immediately after exposure
Secondary Smoking behavior Single item measuring the average number of cigarettes smoked per day in the past two weeks. Two weeks after exposure
See also
  Status Clinical Trial Phase
Completed NCT03999411 - Smartphone Intervention for Smoking Cessation and Improving Adherence to Treatment Among HIV Patients Phase 4
Completed NCT03931772 - Online Automated Self-Hypnosis Program N/A
Completed NCT02649556 - A 26-week Extension of the ZRHR-ERS-09-US Study Evaluating Biological and Functional Changes in Healthy Smokers After Switching to THS 2.2 N/A
Completed NCT03901066 - Smoking Dependence and Periodontitis
Recruiting NCT05846841 - Personalized Tobacco Treatment in Primary Care (MOTIVATE) N/A
Completed NCT03170752 - Implementing and Testing a Cardiovascular Assessment Screening Program (CASP) N/A
Completed NCT03305978 - Pulmonary Nodule Detection: Comparison of an Ultra Low Dose vs Standard Scan. N/A
Completed NCT00000437 - Tobacco Dependence in Alcoholism Treatment (Nicotine Patch/Naltrexone) Phase 4
Completed NCT06105424 - BRP1602: Evaluation of Technical and Logistical Feasibility to Measure Lung Permeability N/A
Active, not recruiting NCT02752022 - Monitoring the Transition From Smoking to E-cigarettes
Completed NCT04340830 - The Effect of Smoking on Dimensional Changes of Free Gingival Graft Around Dental Implants N/A
Completed NCT02901171 - The Contribution of a Smartphone Application to Acceptance and Commitment Therapy Group Treatment for Smoking Cessation N/A
Completed NCT03206619 - A Health Recommeder System to Tailor Message Preferences in a Smoking Cessation Programme
Completed NCT02912000 - TEACH: Technology Evaluation to Address Child Health N/A
Completed NCT02949648 - Electronic Cigarette Use and Quitting in Youth N/A
Completed NCT02945371 - Tailored Inhibitory Control Training to Reverse EA-linked Deficits in Mid-life N/A
Completed NCT02246114 - Self-Monitoring of Carbon Monoxide to Enhance Reproductive Outcomes in Women N/A
Completed NCT02008292 - Acetylcholine, Tobacco Smoking, Genes and Nicotinic Receptors N/A
Completed NCT03448900 - Intervention Study for Smoking Cessation in Spanish College Students N/A
Completed NCT01898507 - Nicotine Metabolism and Low Nicotine Cigarettes N/A